December 5, 2023 Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff November 30, 2023 Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System November 29, 2023 Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023 November 27, 2023 Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution November 8, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights October 24, 2023 Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand October 5, 2023 Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client October 4, 2023 Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option October 2, 2023 Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering September 27, 2023 Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
December 5, 2023 Leading Pan-European Ferry and Logistics Company, P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff
November 30, 2023 Leading Specialist Material Handling Company, Titan Cranes and Rigging Pty Ltd., Adopts Intelligent Fingerprinting Drug Screening System
November 29, 2023 Intelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on December 7, 2023
November 27, 2023 Australian Civil Construction Entity, State Road Constructions, Selects Intelligent Fingerprinting Drug Screening System as Workplace Drug Screening Solution
November 8, 2023 Intelligent Bio Solutions Inc. Reports Fiscal 2024 First Quarter Financial Results and Operational Highlights
October 24, 2023 Intelligent Bio Solutions’ Innovative Drug Screening Technology Now Offered in New Zealand
October 5, 2023 Intelligent Bio Solutions Adds Logistics Firm to Fingerprint Drug Screening Portfolio and Completes Major Milestone with Existing Client
October 4, 2023 Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option
October 2, 2023 Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
September 27, 2023 Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business
